The impact of preoperative CEA and CA 19-9 levels on early and late postoperative outcomes in patients undergoing laparoscopic gastrectomy for gastric adenocarcinoma

Year 2026, Volume: 7 Issue: 2, 198 - 203, 27.03.2026

Hüseyin Kocaaslan , Fatih Sümer

https://izlik.org/JA59WW55MB

Abstract

Aims: The prognostic value of preoperative serum tumor markers in gastric cancer remains controversial. This study aimed to evaluate the association of preoperative carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) levels with clinicopathological characteristics, postoperative outcomes, and overall survival in patients undergoing laparoscopic gastrectomy with D2 lymphadenectomy.
Methods: This retrospective cohort study included patients who underwent laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer. Patients with stage IV disease or those who received neoadjuvant chemotherapy were excluded. Preoperative CEA and CA 19-9 levels were categorized according to standard cutoff values. Clinicopathological characteristics, postoperative complications, resection margin status, and overall survival were analyzed. Kaplan–Meier survival analysis and multivariate Cox and logistic regression models were used to identify independent predictors of outcomes.
Results: A total of 126 patients were included. Elevated preoperative CEA and CA 19-9 levels were observed in 10.3% and 18.3% of patients, respectively. Elevated CA 19-9 levels were significantly associated with advanced tumor depth (T3–4), lymph node metastasis, and lymphovascular invasion, whereas CEA levels showed no significant association with clinicopathological features. Conversion to open surgery was required in 15 patients (11.9%). Major postoperative complications (Clavien–Dindo grade ≥III) occurred in 2.4% of patients and were independently associated with an ASA score ≥3. Multivariate analysis demonstrated that neither CEA nor CA 19-9 levels independently predicted postoperative complications or positive resection margins. During follow-up, 37 deaths were recorded. Overall survival did not differ significantly according to preoperative CEA or CA 19-9 levels. In multivariate Cox regression analysis, pathological stage III was the only independent predictor of overall survival.
Conclusion: Preoperative CA 19-9 levels are associated with aggressive pathological features in gastric cancer but do not independently predict overall survival, postoperative morbidity, or resection margin status in patients undergoing laparoscopic gastrectomy with D2 lymphadenectomy. Serum tumor markers should be interpreted as indicators of tumor burden rather than independent prognostic factors.

Keywords

Gastric cancer , CEA , CA 19-9 , laparoscopic gastrectomy , survival , postoperative complications

Ethical Statement

Ethics Committee Approval: This study was approved by the İnönü University Health Sciences Scientific Research Ethics Committee (Protocol No: 2026/9204) All patient data were anonymized in compliance with confidentiality rules. The study was conducted in accordance with the ethical principles stated in the Declaration of Helsinki. Informed Consent: As the study was designed retrospectively, written informed consent was not obtained from patients. Peer Review Process: Externally peer-reviewed. Conflict of Interest Statement: The authors declare no conflict of interest. Financial Disclosure Statement: The authors declare that this study received no financial support. Author Contributions: All authors declare that they contributed to the design, execution, and analysis of the article and approved the final version.

Supporting Institution

No funding

References

• Luan F, Xu S, Chen K, et al. Prognostic effect of CEA, AFP, CA19 9 and CA242 for recurrence/metastasis of gastric cancer following radical gastrectomy. Mol Clin Oncol. 2024;22(2):17. doi:10.3892/mco.2024.2812
• Qiu X, Shen C, Zhao W, et al. Prognostic value of the combination of HB (hemoglobin) and CEA in resectable gastric cancer. J Cancer. 2022;13(7): 2246-2257. doi:10.7150/jca.67600
• Aksoy A. Mide karsinomunda prediktif faktörler. Genel Tıp Derg. 2016; 26(1):1-7. doi:10.15321/GenelTipDer.20162618129
• Bozan MB, Kanat BH, Yazar FM, et al. Mide kanseri hastalarında preoperatif CEA, AFP ve CA-19.9 düzeylerinin değerlendirilmesi. KSÜ Tıp Fakültesi Derg. 2015;10(3):132-115. doi:10.17576/ksutfd.2015.10. 3. 132115
• Shibata C, Nakano T, Yasumoto A, et al. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. BMC Surg. 2022;22(1):213. doi:10.1186/s12893-022-01667-z
• Li J, Zhao H, Zhang Q, Ren S. Combined albumin and CEA improve prognostic prediction in resectable gastric cancer. Sci Rep. 2025;15(1): 33118. doi:10.1038/s41598-025-18102-x
• Bayrak M, Ölmez ÖF, Kurt E, et al. The relationship between pre-treatment serum levels of AFP, CEA and CA 19-9 and clinicopathological factors in patients with locally advanced and metastatic gastric cancer. Uludağ Tıp Derg. 2011;37(3):139-143.
• Clavien PA, Barkun J, Dindo D, et al. The Clavien-Dindo classification of surgical complications five-year experience. Ann Surg. 2009;250(2):187-196. doi:10.1097/SLA.0b013e3181b13ca2
• Duraker N, Celik AN. The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol. 2001;76(4):266-271. doi:10.1002/jso.1044
• Kim DY, Kim HR, Shim JH, et al. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. J Surg Oncol. 2000;74(3):185-192. doi:10.1002/1096-9098 (200007)74:3<185::aid-jso4>3.0.co;2-0
• Zhou YC, Zhao HJ, Shen LZ. Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases. Asian Pac J Cancer Prev. 2015;16(7):2685-2691. doi:10.7314/apjcp.2015.16.7.2685
• Shimada H, Noie T, Ohashi M, et al. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer. 2014;17(1):26-33. doi:10.1007/s10120-013-0259-5
• Quan Y, Huang A, Ye M, et al. Comparison of laparoscopic versus open gastrectomy for advanced gastric cancer: an updated meta-analysis. Gastric Cancer. 2016;19(3):939-950. doi:10.1007/s10120-015-0516-x
• Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 - tumor marker: past, present, and future. World J Gastrointest Surg. 2020;12(12):468-490. doi:10.4240/wjgs.v12.i12.468
• Suenaga Y, Kanda M, Ito S, et al. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol. 2019;11(1):17-27. doi:10.4251/wjgo.v11.i1.17
• Barman A, Jenny N, Iffat T, et al. Assess the clinical significance of serum CEA and CA 19-9 in patient with gastric cancer. Sch J App Med Sci. 2021;9(6):1083-1092. doi:10.36347/sjams.2021.v09i06.043
• Yu Z, Liang C, Xu Q, et al. Analysis of postoperative complications and long term survival following radical gastrectomy for patients with gastric cancer. Sci Rep. 2024;14(1):23869. doi:10.1038/s41598-024-74758-x